TSXV:SQD.H - Post by User
Post by
FactFinder1994on Apr 29, 2022 2:50pm
156 Views
Post# 34643269
SQI in good company with Quidel.
SQI in good company with Quidel. SQI has yet to informed stakeholders as to the significance of this partnership.
During Calendar Q1, SQI acquired the rights to the FIA Sofia 2 Analyzer for Canada.
SQI to distribute QUIDEL Sofia2 RAPID Antigen Test
The first and Only Health Canada SARS COVID19 RAPID Antigen Test Approved for Asymptomatic Testing
So with a quarter of longterm care homes in Ontario currently experiencing Covid-19 outbreaks, ARE WE offering these tests to these facilities?? What good is it testing asymptomatic visitors with the other rapid tests when they are really only good in the presence of symptoms?
Someone help me here.....Why is this obvious and important asset not being talked about or shared in a significant way. People are dying unnecessarily in these facilities. Please tell us the company is engaged and helping these facilities in great need. The size of the opportunity is significant too.
Seeking AlphaQuidel: A Long-Term Revenue Growth StoryQuidel's revenue will grow at a CAGR of high-single-digits in the next five years. · The company's Sofia, Sofia 2, and Triage MeterPro products....1 week ago